20,000 people affected by 'processing issue' with means-testing system managed by MOH
The majority of those affected received higher-than-intended subsidies and grants, MOH said in a media release on Monday (Jul 21). The rest received subsidies and grants that were lower than intended.
Corrections to subsidy and grant levels are currently being made, following the discovery of the issue, the ministry added.
HOMES typically uses income information from the Inland Revenue Authority of Singapore (IRAS) to means-test individuals with business income, said MOH.
However, in January 2025, the system could not appropriately account for the business incomes of selected individuals following changes in the data processing timelines.
This led to "inaccurate means-testing" for individuals with business incomes and members of their households between Jan 1 and Jan 27.
Around 19,000 people who are under schemes administered by MOH were affected, the Health Ministry said.
Another 1,000 people were also affected despite being under other schemes managed by the Early Childhood Development Agency (ECDA), Ministry of Social and Family Development (MSF), Ministry of Education (MOE), and Infocomm Media Development Authority (IMDA).
This is because "HOMES also provides means-testing results for selected subsidy schemes across the government", MOH added.
Those affected by the issue represent less than 3 per cent of all individuals means-tested during the Jan 1 to Jan 27 period, the ministry said.
Affected schemes and what to expect
AFFECTED MOH SCHEMES
CareShield Life and MediShield Life premium subsidies and Additional Premium Support (APS)
Affected individuals will receive the correct premium subsidies at their next policy renewal. APS recipients will continue to have their premiums covered based on their approved validity period. All affected individuals will be notified via letter. No action is required on their part.
Community Health Assist Scheme (CHAS)
Affected CHAS cardholders will receive letters detailing any required actions, if any.
Subsidies for long-term care services
Affected individuals will receive the corrected subsidies from the next billing cycle or payout date.
Seniors' Mobility and Enabling Fund, Equipment Rental Scheme, Home Caregiving Grant and ElderFund
Affected individuals will be informed of their adjusted subsidy or payout.
Subsidies for day surgeries, inpatient services, specialist outpatient clinics, polyclinic drugs/vaccines and community hospital services
From July 2025, public healthcare institutions will notify individuals who received lower-than-intended subsidies and adjust their bills accordingly. Reimbursements will be issued where applicable. No action is required from individuals.
AFFECTED NON-MOH SCHEMES
ECDA: Preschool subsidies and early intervention schemes
ECDA will inform affected parents, preschools and early intervention centres of the adjusted subsidies from Jul 22. The corrected subsidies will take effect from August 2025 onwards.
IMDA: DigitalAccess@Home Scheme (DAH)
The affected households will be informed from Jul 22. Households who were under-subsidised will receive the correct subsidies and be automatically reimbursed. Those with higher subsidies will continue to receive them for the remaining validity period of the household's current DAH award. Their eligibility will be reviewed when they apply for a new DAH award.
MOE: Higher education bursaries and Kindergarten Care (KCare) additional subsidies
The Institutes of Higher Learning will inform affected students. No action is required from the students. Affected children attending MOE KCare will have their corrected subsidies applied from August 2025 and will be notified accordingly.
SG Enable will work with service providers to inform the affected individuals receiving the subsidies from Jul 22. The corrected subsidies will apply from August 2025 onwards.
MOH said it has completed the reassessment of the affected people and "will adjust their means-test and subsidy tiers back to the intended levels" from Jul 21 onwards.
"For those who received an over-subsidy, they will not have to return the excess subsidy and/or grant amounts that have already been paid," the ministry said.
"For the minority of individuals who received lower than intended subsidies and/or) grants, agencies will make good the difference."
MOH said that the agencies will reach out to inform affected individuals progressively, and there is no action required on their part.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNA
25 minutes ago
- CNA
CNA938 Rewind - Eat, Drink, Singapore - Celebrating SG60 at Edge
CNA938 Rewind - Why the need for an Asia-specific allergic rhinitis database Singapore is developing Asia's first allergic rhinitis database. The condition – commonly known as hay fever – is triggered by allergens such as dust, pollen and pet dander. Andrea Heng and Hairianto Dimand speak with Koh Tze Sin, a 26 year-old Singaporean living with Allergic Rhinitis for hear a first hand account. They also speak with Adjunct Associate Professor Ng Chew Lip, Senior Consultant, Department of Otolaryngology - Head & Neck Surgery (ENT) and the principal investigator of Project ENTenna to find out more about the study.


Asia News Network
2 hours ago
- Asia News Network
Bhutan sees climb in TB, HIV, and malaria cases despite strong systems
July 24, 2025 THIMPHU – The Annual Health Bulletin 2025 of the Ministry of Health (MoH) reveals clear patterns in the country's ongoing battle against infectious diseases, with tuberculosis (TB), HIV/AIDS, and malaria continuing to pose significant public health challenges. Despite robust surveillance and health infrastructure, the data indicate a mixed trend, with some diseases showing concerning increase in reported cases, demanding sustained and strategic interventions. Tuberculosis remains a persistent threat, with the number of reported cases increasing steadily over the last three years. In 2023, Bhutan registered 864 TB cases. This rose to 920 cases in 2024, reflecting a continuing burden despite the country's comprehensive TB control strategy. The National Tuberculosis Control Programme (NTCP) has been instrumental in leading these efforts, ensuring diagnostic and treatment services are accessible even in remote regions. Yet, multidrug-resistant TB (MDR-TB), treatment non-compliance, and disease relapse remain significant challenges. In 2024 alone, there were 38 pulmonary TB relapses and 17 extrapulmonary TB relapses. The majority of TB cases in 2024 (65 percent) were pulmonary, with 552 confirmed through bacteriological testing. A substantial proportion occurred in the economically active age group, mirroring the 2023 data, which showed the highest incidence among the 15–24-year demographic, especially females. In 2023, 98 females and 72 males were diagnosed with new pulmonary bacteriologically confirmed TB, with extrapulmonary TB cases also skewing heavily towards younger females. These patterns underscore a need for age- and gender-specific interventions, improved awareness, and strengthened diagnostic coverage, particularly in youth populations. The rise in total TB cases from 809 in 2022 to 920 in 2024 reflects the ongoing struggle to fully contain transmission and the importance of maintaining high-quality treatment adherence and education efforts. HIV/AIDS trends also show a steady rise in new infections. In 2023, 61 new cases were reported, rising to 85 in 2024, bringing the cumulative number of HIV infections since 1993 to 1,020. Deaths attributed to HIV have also increased from 6 in 2023 to 21 in 2024, highlighting the disease's ongoing impact despite the country's commitment to the 95–95–95 UNAIDS targets. As of December 2024, 774 people are living with HIV in Bhutan, with 98 percent of them receiving antiretroviral therapy (ART). The introduction of Pre-exposure Prophylaxis (PrEP) in 2024 for high-risk groups in Paro and Thimphu marked a progressive step in preventive care. However, the continuous rise in new infections underscores the need to expand such measures nationwide and further strengthen HIV awareness, testing, and treatment adherence. While Bhutan has made significant strides toward malaria elimination, the 2024 data revealed an unexpected and sharp resurgence in cases, rising to 144 from just 18 in 2023 and 6 in 2022. This more than four-fold increase is attributed primarily to a large outbreak across the border in Assam, India. Bhutan's real-time surveillance and containment systems proved effective in localising the impact, with cases confined to border districts. Of the 144 cases, 71 were imported, and 73 introduced, resulting from transmission following cross-border exposure. However, none were indigenous cases, confirming that internal transmission remains effectively controlled. Plasmodium vivax accounted for approximately 95 percent of all infections. The demographic most affected by malaria in 2024 was the 15–49 age group (65 percent), which represents the most mobile and economically active section of the population. Males were disproportionately impacted (73 percent), largely due to their roles in border-related occupations such as forestry, farming, and security. This occupational exposure highlights the importance of targeted malaria interventions for high-risk groups and the need for stronger cross-border coordination to prevent future outbreaks. The absence of indigenous malaria cases supports Bhutan's continued progress toward WHO malaria elimination certification, but the sudden spike in cases in 2024 demonstrates how vulnerable even well-controlled systems remain to regional epidemiological dynamics. The latest data showing rising trends in TB, HIV/AIDS, and malaria underscores the need for more targeted and strategic interventions, despite the progress Bhutan has made in tackling these diseases.


CNA
3 hours ago
- CNA
CNA938 Rewind - Why the need for an Asia-specific allergic rhinitis database
CNA938 Rewind - Why the need for an Asia-specific allergic rhinitis database Singapore is developing Asia's first allergic rhinitis database. The condition – commonly known as hay fever – is triggered by allergens such as dust, pollen and pet dander. Andrea Heng and Hairianto Dimand speak with Koh Tze Sin, a 26 year-old Singaporean living with Allergic Rhinitis for hear a first hand account. They also speak with Adjunct Associate Professor Ng Chew Lip, Senior Consultant, Department of Otolaryngology - Head & Neck Surgery (ENT) and the principal investigator of Project ENTenna to find out more about the study.